Stockreport

Merck: The Spike Doesn't Make It Overvalued [Seeking Alpha]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF Keytruda, MRK's top-selling drug, faces a 2028 patent cliff, but ongoing innovation and new approvals like Qlex aim to mitigate revenue risk. Despite Gardasil's recen [Read more]